Search Results
Real-world efficacy of brentuximab vedotin as consolidation therapy in patients with HL
The real-world efficacy of brentuximab vedotin consolidation post-autoSCT in R/R HL
Brentuximab vedotin: current status and future considerations for this agent in HL treatment
Current indications for the use of brentuximab vedotin in Hodgkin lymphoma
Updates on the use of brentuximab vedotin in later-stage HL
Treatment options for patients with Hodgkin lymphoma who progress after brentuximab vedotin
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma
Debate: Best upfront approach for Advanced Stage Hodgkin Lymphoma? - A (brentuximab vedotin) VD
Brentuximab vedotin for CTCL
Brentuximab Vedotin based therapy of Hodgkin Lymphoma
Brentuximab vedotin, nivolumab, doxorubicin & dacarbazine for early stage classical Hodgkin lymphoma
Brentuximab vedotin versus pembrolizumab in R/R classical Hodgkin lymphoma
